Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and effectiveness of one dose strength of
Denufosol compared to placebo in patients with CF and a predicted FEV1 of greater than or
equal to 75% but less than or equal to 110% predicted.